期刊文献+

新型沸石止血纱布的生物安全性研究

Biosafety study on new zeolite hemostatic gauze
下载PDF
导出
摘要 目的研究新型沸石止血纱布的生物安全性。方法参照GB/T 16886医疗器械生物学评价标准和GB/T 14233.2-2005《中华人民共和国药典》对新型沸石止血纱布进行安全性研究,采用CCK8法进行体外细胞毒性试验、溶血试验、热原试验、急性全身毒性试验、皮内反应试验和致敏试验。结果新型沸石止血纱布细胞毒性等级均在0~1,溶血率为3.37%,热原试验、急性全身毒性试验、皮内反应和致敏试验均呈阴性。结论新型沸石止血纱布生物安全性较好。 Objective To study the biosafety of new zeolite hemostatic gauze.Methods According to GB/T 16886 biological evaluation standard for medical devices and GB/T 14233.2-2005“Pharmacopoeia of the People’s Republic of China”,the safety of the new zeolite hemostatic sponge was studied.CCK8 method was used for in vitro cytotoxicity test,hemolysis test,pyrogen test,acute systemic toxicity test,intradermal reaction test and sensitization test.Results The cytotoxicity grade of the new zeolite hemostatic gauze was 0-1.The hemolysis rate was 3.37%.The pyrogen test,acute systemic toxicity test,intradermal reaction and sensitization test were all negative.Conclusions The new zeolite hemostatic gauze is characterized by better biosafety.
作者 马玥 张莹 孙琦 史振伟 黄转青 杨飞 石浩源 杨亚龙 徐风华 MA Yue;ZHANG Ying;SUN Qi;SHI Zhenwei;HUANG Zhuanqing;YANG Fei;SHI Haoyuan;YANG Yalong;XU Fenghua(Pharmaceutical Sciences Research Division,Department of Pharmacy,Medical Supplies Centre of Chinese PLA General Hospital,Beijing 100853,China;Medical School of Chinese PLA,Beijing 100853,China)
出处 《武警医学》 CAS 2023年第4期301-304,共4页 Medical Journal of the Chinese People's Armed Police Force
基金 军队生物安全专项(19SWAQ28-4)
关键词 沸石 止血 生物安全性 zeolite hemostasis biosafety
  • 相关文献

参考文献3

二级参考文献44

  • 1Ne, A. E.; Madler, L.; Velegol, D.; Xia, T.; Hoek, E. M. V.; Somasundaran, P. Understanding biophysicochemical interac- tions at the nano-bio interface. Nat. Mater. 2009, 8, 543-557.
  • 2Tenzer, S.; Docter, D.; Kuharev, J.; Musyanovych, A.; Fetz, V.; Hecht, R. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotechnol. 2013, 8, 772-781.
  • 3Cedervall, T.; Lynch, I.; Foy, M.; Berggad, T.; Donnelly, S. C.; Cagney, G. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew. Chem. Int. Ed. 2007, 46, 5754-5756.
  • 4Lundqvist, M.; Stigler, J.; Ella, G.; Lynch, I.; Cedervall, T.; Dawson, K. A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. USA 2008, 105, 14265-14270.
  • 5Casals, E.; Pfaller, T.; Duschl, A.; Oostingh, G. J.; Puntes, V. Time evolution of the nanoparticle protein corona. ACS Nano. 2010, 4, 3623-3632.
  • 6Lundqvist, M.; Stigler, J.; Cedervall, T.; Berggard, T.; Flanagan, M. B.; Lynch, I. The evolution of the protein corona around nanoparticles: A test study. ACS Nano. 2011, 5, 7503-7509.
  • 7Monopoli, M. P.; Walczyk, D.; Campbell, A.; Elia, G.; Lynch, I.; Bombelli, F. B. Physical~hemical aspects of protein corona: Relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 2011, 133, 2525-2534.
  • 8Tenzer, S.; Docter, D.; Rosfa, S.; Wlodarski, A.; Kuharev, J.; Rekik, A. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: A com- prehensive quantitative proteomic analysis. ACS Nano. 2011, 5, 7155-7167.
  • 9Walkey, C. D.; Olsen, J. B.; Guo, H. B.; Emili, A.; Chan, W C. W. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 2012, 134, 2139 2147.
  • 10Walkey, C. D.; Chan, W. C. W. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem, Soc. Rev. 2012, 41, 2780~799.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部